These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31754956)

  • 1. System X
    Nehser M; Dark J; Schweitzer D; Campbell M; Zwicker J; Hitt DM; Little H; Diaz-Correa A; Holley DC; Patel SA; Thompson CM; Bridges RJ
    Neurochem Res; 2020 Jun; 45(6):1375-1386. PubMed ID: 31754956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel analogs of sulfasalazine as system x
    Patel D; Kharkar PS; Gandhi NS; Kaur E; Dutt S; Nandave M
    Drug Dev Res; 2019 Sep; 80(6):758-777. PubMed ID: 31199023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel di-aryl-substituted isoxazoles act as noncompetitive inhibitors of the system Xc(-) cystine/glutamate exchanger.
    Newell JL; Keyari CM; McDaniel SW; Diaz PJ; Natale NR; Patel SA; Bridges RJ
    Neurochem Int; 2014 Jul; 73():132-8. PubMed ID: 24333322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of xc⁻ transporter-mediated cystine uptake by sulfasalazine analogs.
    Shukla K; Thomas AG; Ferraris DV; Hin N; Sattler R; Alt J; Rojas C; Slusher BS; Tsukamoto T
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6184-7. PubMed ID: 21889337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
    Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
    Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
    Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
    Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
    PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.
    Matti AA; Mirzaei J; Rudolph J; Smith SA; Newell JL; Patel SA; Braden MR; Bridges RJ; Natale NR
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5931-5. PubMed ID: 24042010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of cystine across xC
    Ghasemitarei M; Yusupov M; Razzokov J; Shokri B; Bogaerts A
    Arch Biochem Biophys; 2019 Mar; 664():117-126. PubMed ID: 30738038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfasalazine attenuates ACL transection and medial menisectomy-induced cartilage destruction by inhibition of cystine/glutamate antiporter.
    Tsai WY; Tsai RY; Liu CC; Wu JL; Wong CS
    J Orthop Res; 2016 Apr; 34(4):650-7. PubMed ID: 26466556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity-Relationship-Aided Design and Synthesis of xCT Antiporter Inhibitors.
    Cirillo D; Sarowar S; Øyvind Enger P; Bjørsvik HR
    ChemMedChem; 2021 Sep; 16(17):2650-2668. PubMed ID: 33847044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
    Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
    Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.
    Bridges RJ; Natale NR; Patel SA
    Br J Pharmacol; 2012 Jan; 165(1):20-34. PubMed ID: 21564084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore model.
    Patel SA; Rajale T; O'Brien E; Burkhart DJ; Nelson JK; Twamley B; Blumenfeld A; Szabon-Watola MI; Gerdes JM; Bridges RJ; Natale NR
    Bioorg Med Chem; 2010 Jan; 18(1):202-13. PubMed ID: 19932968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine for brain cancer fits.
    Sontheimer H; Bridges RJ
    Expert Opin Investig Drugs; 2012 May; 21(5):575-8. PubMed ID: 22404218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM; Knight LJ; Donaldson PJ; Lim JC
    Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of cystine uptake and inhibition pattern of sulfasalazine in A549 cells.
    Okamoto K; Saito Y; Ueda H; Narumi K; Furugen A; Kobayashi M
    Biopharm Drug Dispos; 2021 Sep; 42(8):389-392. PubMed ID: 34287957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lathyrus excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid is a substrate of the L-cystine/L-glutamate exchanger system xc-.
    Warren BA; Patel SA; Nunn PB; Bridges RJ
    Toxicol Appl Pharmacol; 2004 Oct; 200(2):83-92. PubMed ID: 15476861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oxidative stress on cystine transportation by xC‾ antiporter.
    Ghasemitarei M; Yusupov M; Razzokov J; Shokri B; Bogaerts A
    Arch Biochem Biophys; 2019 Oct; 674():108114. PubMed ID: 31557465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.